I-Mab Announces IND Approval by FDA to Initiate Phase 1 Study for Protollin for the Treatment of ...

Retrieved on: 2021-07-31 16:18:45

Tags for this article:

Click the tags to see associated articles and topics

I-Mab Announces IND Approval by FDA to Initiate Phase 1 Study for Protollin for the Treatment of .... View article details on hiswai:

Excerpt

SHANGHAI, China and GAITHERSBURG, MD, USA I July 30, 2021 I I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical ...

Article found on: pipelinereview.com